VIPoma: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
| Line 10: | Line 10: | ||
{{CMG}}; {{AE}}{{MSI}} {{PSD}} | {{CMG}}; {{AE}}{{MSI}} {{PSD}} | ||
{{SK}} Watery diarrhea with hypokalemic alkalosis; WDHA syndrome; pancreatic cholera syndrome; Verner-Morrison syndrome. | {{SK}} [[Watery diarrhea with hypokalemic alkalosis]]; [[WDHA syndrome]]; [[pancreatic cholera syndrome]]; [[Verner-Morrison syndrome|Verner-Morrison syndrome.]] | ||
==[[VIPoma overview|Overview]]== | ==[[VIPoma overview|Overview]]== | ||
Revision as of 13:27, 10 September 2019
| VIPoma | |
 | |
|---|---|
| Pancreatic vipoma. Electron microscopy of a pancreatic VIPoma. Abundant secretory granules of variable size, shape, and density in a pancreatic tumor with WDHA syndrome. Abundant PP-and a few VIP-immunoreactive cells (inset) were detected by light microscopic immunohistochemistry of the same tumor (X28.000). Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology |
For patient information, click here
|
VIPoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
VIPoma On the Web |
|
American Roentgen Ray Society Images of VIPoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2] Parminder Dhingra, M.D. [3]
Synonyms and keywords: Watery diarrhea with hypokalemic alkalosis; WDHA syndrome; pancreatic cholera syndrome; Verner-Morrison syndrome.
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating VIPoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies